|
|
Gene Symbol |
AKR1C3 |
|
Aliases |
DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS |
|
Entrez Gene ID |
|
|
Gene Name |
Aldo-keto reductase family 1 member C3 |
|
Chromosomal Location |
10p15.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0006693 |
Biological process |
Prostaglandin metabolic process |
IBA |
21873635 |
GO:0006693 |
Biological process |
Prostaglandin metabolic process |
IEP |
20036328 |
GO:0006693 |
Biological process |
Prostaglandin metabolic process |
TAS |
9792917 |
GO:0007186 |
Biological process |
G protein-coupled receptor signaling pathway |
IDA |
18508192 |
GO:0007584 |
Biological process |
Response to nutrient |
IEP |
19007764 |
GO:0008202 |
Biological process |
Steroid metabolic process |
IBA |
21873635 |
GO:0008202 |
Biological process |
Steroid metabolic process |
IEP |
20036328 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IDA |
18508192, 20036328 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IMP |
21851338 |
GO:0008584 |
Biological process |
Male gonad development |
IEP |
19942269 |
GO:0009267 |
Biological process |
Cellular response to starvation |
IEP |
18641923 |
GO:0010942 |
Biological process |
Positive regulation of cell death |
IDA |
21787718 |
GO:0016488 |
Biological process |
Farnesol catabolic process |
IDA |
21187079 |
GO:0030216 |
Biological process |
Keratinocyte differentiation |
IEP |
22170488 |
GO:0034614 |
Biological process |
Cellular response to reactive oxygen species |
IDA |
21787718 |
GO:0042448 |
Biological process |
Progesterone metabolic process |
IBA |
21873635 |
GO:0042448 |
Biological process |
Progesterone metabolic process |
IDA |
21232532 |
GO:0042574 |
Biological process |
Retinal metabolic process |
IDA |
21851338 |
GO:0043170 |
Biological process |
Macromolecule metabolic process |
IEP |
18641923 |
GO:0044597 |
Biological process |
Daunorubicin metabolic process |
IBA |
21873635 |
GO:0044597 |
Biological process |
Daunorubicin metabolic process |
IMP |
20837989 |
GO:0044598 |
Biological process |
Doxorubicin metabolic process |
IBA |
21873635 |
GO:0044598 |
Biological process |
Doxorubicin metabolic process |
IMP |
20837989 |
GO:0048385 |
Biological process |
Regulation of retinoic acid receptor signaling pathway |
IDA |
21851338 |
GO:0051897 |
Biological process |
Positive regulation of protein kinase B signaling |
IDA |
18508192 |
GO:0055114 |
Biological process |
Oxidation-reduction process |
IDA |
16983398, 19442656, 21232532 |
GO:0055114 |
Biological process |
Oxidation-reduction process |
TAS |
9792917 |
GO:0061370 |
Biological process |
Testosterone biosynthetic process |
IMP |
16983398 |
GO:0070293 |
Biological process |
Renal absorption |
NAS |
16157291 |
GO:0071276 |
Biological process |
Cellular response to cadmium ion |
IDA |
21787718 |
GO:0071277 |
Biological process |
Cellular response to calcium ion |
IDA |
22170488 |
GO:0071379 |
Biological process |
Cellular response to prostaglandin stimulus |
IDA |
22170488 |
GO:0071384 |
Biological process |
Cellular response to corticosteroid stimulus |
IDA |
19336506 |
GO:0071395 |
Biological process |
Cellular response to jasmonic acid stimulus |
IDA |
19487289 |
GO:0071799 |
Biological process |
Cellular response to prostaglandin D stimulus |
IDA |
18508192 |
GO:1900053 |
Biological process |
Negative regulation of retinoic acid biosynthetic process |
IDA |
21851338 |
GO:2000224 |
Biological process |
Regulation of testosterone biosynthetic process |
IMP |
19336506 |
GO:2000353 |
Biological process |
Positive regulation of endothelial cell apoptotic process |
IDA |
19442656 |
GO:2000379 |
Biological process |
Positive regulation of reactive oxygen species metabolic process |
IDA |
19442656 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
18574251 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
18574251, 19336506, 19942269, 22170488 |
GO:0005829 |
Cellular component |
Cytosol |
IBA |
21873635 |
GO:0070062 |
Cellular component |
Extracellular exosome |
HDA |
23533145 |
GO:0001758 |
Molecular function |
Retinal dehydrogenase activity |
IDA |
21851338 |
GO:0004032 |
Molecular function |
Alditol:NADP+ 1-oxidoreductase activity |
IBA |
21873635 |
GO:0004032 |
Molecular function |
Alditol:NADP+ 1-oxidoreductase activity |
IDA |
21232532 |
GO:0004033 |
Molecular function |
Aldo-keto reductase (NADP) activity |
TAS |
9792917 |
GO:0004745 |
Molecular function |
Retinol dehydrogenase activity |
IDA |
21851338 |
GO:0008106 |
Molecular function |
Alcohol dehydrogenase (NADP+) activity |
IBA |
21873635 |
GO:0016229 |
Molecular function |
Steroid dehydrogenase activity |
IBA |
21873635 |
GO:0016491 |
Molecular function |
Oxidoreductase activity |
IBA |
21873635 |
GO:0016655 |
Molecular function |
Oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
IDA |
19442656, 20837989 |
GO:0018636 |
Molecular function |
Phenanthrene 9,10-monooxygenase activity |
IDA |
21851338 |
GO:0035410 |
Molecular function |
Dihydrotestosterone 17-beta-dehydrogenase activity |
IDA |
16983398 |
GO:0045550 |
Molecular function |
Geranylgeranyl reductase activity |
IDA |
21187079 |
GO:0045703 |
Molecular function |
Ketoreductase activity |
IDA |
19487289 |
GO:0047020 |
Molecular function |
15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity |
IDA |
22170488 |
GO:0047023 |
Molecular function |
Androsterone dehydrogenase activity |
IBA |
21873635 |
GO:0047023 |
Molecular function |
Androsterone dehydrogenase activity |
IDA |
16983398 |
GO:0047086 |
Molecular function |
Ketosteroid monooxygenase activity |
IBA |
21873635 |
GO:0047086 |
Molecular function |
Ketosteroid monooxygenase activity |
IDA |
21232532 |
GO:0047787 |
Molecular function |
Delta4-3-oxosteroid 5beta-reductase activity |
IDA |
16983398 |
|
Protein Information |
|
Protein Name |
Aldo-keto reductase family 1 member C3, 3-alpha hydroxysteroid dehydrogenase, type II, 3-alpha-HSD type II, brain, chlordecone reductase homolog HAKRb, dihydrodiol dehydrogenase 3, dihydrodiol dehydrogenase X, indanol dehydrogenase, prostaglandin F synthase, testosterone 17-beta-dehydrogenase 5, trans-1,2-dihydrobenzene-1,2-diol dehydrogenase, type IIb 3-alpha hydroxysteroid dehydrogenase |
|
Function |
Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone |
|
|
|
|
|
UniProt |
|
|
PDB |
1RY0, 1RY8, 1S1P, 1S1R, 1S2A, 1S2C, 1XF0, 1ZQ5, 2F38, 2FGB, 3R43, 3R58, 3R6I, 3R7M, 3R8G, 3R8H, 3R94, 3UFY, 3UG8, 3UGR, 3UWE, 4DBS, 4DBU, 4DBW, 4DZ5, 4FA3, 4FAL, 4FAM, 4H7C, 4HMN, 4WDT, 4WDU, 4WDW, 4WDX, 4WRH, 4XVD, 4XVE, 4YVV, 4YVX, 4ZFC, 5HNT, 5HNU, 5JM5, 6F2U, 6F78 |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000242208 |
P08476 |
P08476 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
Disorders of Sex Development |
|
Hermaphroditism |
|
Pseudohermaphroditism |
|
Ambiguous Genitalia |
|
Intersex Conditions |
|
Sex Differentiation Disorders |
|
PCOS |
|
Neoplasms |
Prostate cancer |
|
Ovarian Cancer |
|
Stomach Cancer |
|
Endometrial Cancer |
|
Gastric Cancer |
|
Nutritional and Metabolic Diseases |
Obesity |
|
Psychiatric/Brain disorders |
Bipolar Disorder |
|
Reproductive disorders |
Endometriosis |
|
Endometrioma |
|
Preeclampsia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
Testosterone |
PCOS |
(SNP)-71G |
Rotterdam criteria |
Related
|
Caucasian, African-American, Hispanic, Asian (121 PCOS patients and 128 population controls ) |
SNP-71G in HSD17B5 is a functional polymorphism that may contribute to testosterone excess in a subset of PCOS patients. |
|
Testosterone, Follicle-stimulating hormone (FSH), luteinizing hormone (LH), LH/FSH, and estradiol (E(2)) |
PCOS |
rs898611 |
|
Related
|
222 PCOS patients, 283 controls |
Our data suggest that there is no association of HSD17B6 and HSD17B5 variants with the occurrence of PCOS in the Chinese population, but the polymorphism of SNP rs898611 is associated with BMI in PCOS patients. |
|
Testosterone, Androstenedione |
PCOS, hyperandrogenemia |
71A/G HSD17B5 SNP, -71G HSD17B5 |
Rotterdam criteria, NIH/NIHCD criteria |
Related
|
150 caucasian Greek PCOS women with biochemical hyperandrogenism and chronic anovulation, 51 healthy control subjects |
The -71G HSD17B5 variant is not a major component of the molecular pathogenetic mechanisms of PCOS, although it might contribute to the severity of hyperandrogenemia in women with PCOS and biochemical hyperandrogenism |
|
Testosterone |
PCOS, hyperandrogenemia |
rs3763676, rs12529, rs7741, rs12387 |
|
Related
|
Barcelona, Spain (190 girls with precocious pubarche (PP), 71 healthy controls) |
HSD17B5 SNPs predicted to have functional effects do not appear to be a risk factor for PP in girls from Barcelona, despite these girls being at high risk of developing androgen excess in adulthood. |
|
HSD17B6 |
PCOS |
rs1937845 |
|
Direct
|
Chinese (335 patients with PCOS and 354 controls). |
In conclusion, our findings showed a significant statistical association between HSD17B5 rs1937845 and PCOS risk in Chinese women. |
|
|
|